Brief: Invivo Therapeutics Announces Topline Data From Pivotal Inspire 2.0 Study In Acute Spinal Cord Injury
March 9 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS ANNOUNCES TOPLINE DATA FROM PIVOTAL
INSPIRE
2.0 STUDY IN ACUTE SPINAL CORD INJURY
* INVIVO THERAPEUTICS HOLDINGS - PIVOTAL INSPIRE 2.0 STUDY
DID NOT
ACHIEVE PRIMARY ENDPOINT OF DEFINED IMPROVEMENT ON STANDARD
IMPAIRMENT SCALE
* INVIVO THERAPEUTICS HOLDINGS CORP - STUDY DID NOT MEET ITS
PRIMARY ENDPOINT
Source text for Eikon: ID:nBwbKRzx9a
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR